MiR-520b as a novel molecular target for suppressing stemness phenotype of head-neck cancer by inhibiting CD44
Abstract Cancer stem cells preferentially acquire the specific characteristics of stress tolerance and high mobility, allowing them to progress to a therapy-refractive state. To identify a critical molecule to regulate cancer stemness is indispensable to erratically cure cancer. In this study, we id...
Guardado en:
Autores principales: | Ya-Ching Lu, Ann-Joy Cheng, Li-Yu Lee, Guo-Rung You, Yan-Liang Li, Hsin-Ying Chen, Joseph T. Chang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7955a3e3428748188f5cdcffdeff18f9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Role of CD44 as a marker of cancer stem cells in head and neck cancer
por: Trapasso S, et al.
Publicado: (2012) -
Targeting CD44v6 for fluorescence-guided surgery in head and neck squamous cell carcinoma
por: Julia Odenthal, et al.
Publicado: (2018) -
Network modeling identifies molecular functions targeted by miR-204 to suppress head and neck tumor metastasis.
por: Younghee Lee, et al.
Publicado: (2010) -
FGF16 regulated by miR-520b enhances the cell proliferation of lung cancer
por: He Wenfeng, et al.
Publicado: (2021) -
NUMB suppression by miR-9-5P enhances CD44+ prostate cancer stem cell growth and metastasis
por: Xuan Wang, et al.
Publicado: (2021)